• Endocannabinoid Signaling in Autism
• Mutations found in individuals with autism interfere with endocannabinoid signaling in the brain
• Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders
• A novel approach to the symptomatic treatment of autism
• Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders 
• Targeting the endocannabinoid system in the treatment of fragile X syndrome
• Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling